A potential therapeutic agent for the treatment of hyperuricemia and gout: 3,4-Dihydroxy-5-nitrobenzaldehyde phenylthiosemicarbazide
Article in European Journal of Pharmaceutical Sciences (April 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in European Journal of Pharmaceutical Sciences (April 2024)
Article in Journal of Applied Toxicology (October 2023)
Article in Journal of Herbal Medicine (September 2023)